Thermo Fisher Scientific (TMO) Financials
Thermo Fisher Scientific (TMO) Historical Financial Statements and Key Metrics for 1994 - 2023
Full Thermo Fisher Scientific financials for 1994 - 2023 are available in the
US Historical Financials dataset
All financial data is sourced direct from SEC 10-Q and 10-K filings, restatements are included.
Thermo Fisher Scientific Income Statements
(in $ 000,000's)
| Quarter End | Revenue | Gross Profit | Operating Income | Net Income | EBITDA | EPS |
| 2023-Dec-31 | 10,886 | 4,496 (41.3 %) | 1,854 (17.0 %) | 1,630 (15.0 %) | 1,854 | 4.20 |
| 2023-Sep-30 | 10,574 | 4,429 (41.9 %) | 1,864 (17.6 %) | 1,715 (16.2 %) | 3,061 | 4.42 |
| 2023-Jul-01 | 10,687 | 4,364 (40.8 %) | 1,578 (14.8 %) | 1,361 (12.7 %) | 2,794 | 3.51 |
| 2023-Apr-01 | 10,710 | 4,273 (39.9 %) | 1,563 (14.6 %) | 1,289 (12.0 %) | 2,634 | 3.32 |
| 2023-Mar-31 | 10,710 | 4,273 (39.9 %) | 1,563 (14.6 %) | 1,289 (12.0 %) | 2,634 | 3.32 |
| 2022-Dec-31 | 11,450 | 4,735 (41.4 %) | 1,861 (16.3 %) | 1,576 (13.8 %) | 2,866 | 4.01 |
| 2022-Oct-01 | 10,677 | 4,302 (40.3 %) | 1,710 (16.0 %) | 1,495 (14.0 %) | 2,537 | 3.79 |
Full historical income statements for 1994 - 2023 is included in the
US Historical Financials dataset.
Thermo Fisher Scientific Balance Sheets
(in $ 000,000's)
| Quarter End | Total Assets | Total Liabilities | Total Debt | Total Equity | Cash & Equivalents |
| 2023-Dec-31 | 98,726 | 51,884 | 34,917 | 46,724 | 8,077 |
| 2023-Sep-30 | 97,057 | 51,593 | 35,284 | 45,328 | 6,151 |
| 2023-Jul-01 | 94,105 | 50,190 | 34,008 | 43,802 | 3,133 |
| 2023-Apr-01 | 94,658 | 52,225 | 35,257 | 42,310 | 3,482 |
| 2023-Mar-31 | 94,658 | 52,225 | 35,257 | 42,310 | 3,482 |
| 2022-Dec-31 | 97,290 | 53,258 | 34,488 | 44,032 | 8,524 |
| 2022-Oct-01 | 90,536 | 46,809 | 29,160 | 43,549 | 2,919 |
Full historical balance sheet data for 1994 - 2023 is included in the
US Historical Financials dataset.
Thermo Fisher Scientific Cash Flow Statements
(in $ 000,000's)
| Quarter End | Operating Cash Flow | Investing | Financing | Free Cash Flow |
| 2023-Dec-31 | 3,723 | -376 | -1,428 | 3,318 |
| 2023-Sep-30 | 2,414 | -1,181 | 1,855 | 2,082 |
| 2023-Jul-01 | 1,540 | -443 | -1,456 | 1,256 |
| 2023-Apr-01 | 729 | -3,142 | -2,593 | 271 |
| 2023-Mar-31 | 729 | -3,142 | -2,593 | 271 |
| 2022-Dec-31 | 3,487 | -525 | 2,391 | 2,937 |
| 2022-Oct-01 | 1,937 | -545 | -151 | 1,390 |
Full historical cash flow data for 1994 - 2023 is included in the
US Historical Financials dataset.
Thermo Fisher Scientific Key Valuation and Operating Metrics
| Quarter End | Market Capitalization ($ 000,000's) |
Enterprise Value ($ 000,000's) |
Price/Earnings ($ 000,000's) |
Price/Sales ($ 000,000's) |
Price/Book ($ 000,000's) |
| 2023-Dec-31 | 205,416 | 232,256 | 18.87 | 31.51 | 4.40 |
| 2023-Sep-30 | 195,382 | 224,515 | 18.48 | 28.48 | 4.31 |
| 2023-Jul-01 | 201,396 | 232,270 | 18.84 | 36.99 | 4.60 |
| 2023-Apr-01 | 222,479 | 254,254 | 20.77 | 43.15 | 5.26 |
| 2023-Mar-31 | 222,479 | 254,254 | 20.77 | 43.15 | 5.26 |
| 2022-Dec-31 | 215,320 | 241,284 | 18.81 | 34.16 | 4.89 |
| 2022-Oct-01 | 198,818 | 225,059 | 18.62 | 33.25 | 4.57 |
Full historical valuation and operating metrics for 1994 - 2023 are included in the
US Historical Financials dataset.